SKYE
Skye Bioscience, Inc.
-0.05 (-2.94%)1.65USD40.1K成交股數58.4M市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-09下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 3.9M | 7.9M | 11.5M | 9.4M | 14.3M | 7.2M | 4.9M | 4.1M | 1.9M | 1.6M | 1.3M | 1.8M |
| 銷售管理費用 | 3.9M | 4.7M | 3.4M | 3.9M | 3.9M | 4.6M | 4.6M | 4.3M | 4.2M | 2.5M | 2.2M | 1.2M |
| 營業利益 | −11.1M-39% | −12.7M+8% | −14.9M+200% | −13.3M+58% | −18.2M+197% | −11.8M+188% | −5.0M-80% | −8.4M+196% | −6.2M | −4.1M | −24.7M | −2.8M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −10.8M-39% | −12.5M+13% | −14.4M+270% | −12.8M+61% | −17.6M+251% | −11.1M+151% | −3.9M-84% | −7.9M+154% | −5.0M | −4.4M | −24.9M | −3.1M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.27-39% | -0.32+14% | -0.37+270% | -0.32+60% | -0.44+144% | -0.28+833% | -0.10-97% | -0.20-75% | -0.18 | -0.03 | -3.17 | -0.80 |
| 稀釋股數 | 39.7M | 39.7M | 39.7M | 39.7M | 39.7M | 39.7M | 38.8M | 38.7M | 28.0M | 7.0M | 7.9M | 3.9M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 8.1M | 8.1M | 5.9M | 18.4M | 23.8M | 46.4M | 67.4M | 74.1M | 83.3M | 1.3M | 5.1M | 553K |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 11.0M | 19.4M | 28.3M | 41.3M | 52.2M | 64.8M | 81.5M | 87.3M | 94.8M | 11.9M | 15.6M | 2.2M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 11.5M | 10.4M | 8.3M | 8.5M | 8.5M | 5.5M | 5.7M | 14.5M | 16.0M | 14.1M | 13.9M | 10.0M |
| 股東權益 | −497K | 9.0M | 20.0M | 32.8M | 43.7M | 59.3M | 75.8M | 72.8M | 78.9M | −2.1M | 1.7M | −7.8M |
| 負債比 | 104.5% | 53.6% | 29.3% | 20.5% | 16.3% | 8.6% | 7.0% | 16.6% | 16.8% | 117.9% | 89.1% | 448.4% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −8.6M-7% | – | – | – | −9.2M | – | – | −4.7M | – | – | – |
| 資本支出 | – | 0.00 | – | – | – | 6K | – | – | 3K | – | – | – |
| 自由現金流 | – | −8.6M-7% | – | – | – | −9.2M | – | – | −4.7M | – | – | – |
| 折舊攤銷 | – | 173K | – | – | – | 177K | 48K | – | 28K | – | 13K | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −55.9M | –% | -1.41 | −43.1M |
| FY2024 | – | – | −26.6M | –% | -0.73 | −26.8M |
| FY2023 | – | – | −37.6M | –% | -5.37 | −14.0M |
| FY2022 | – | – | −19.5M | –% | -8.77 | −12.8M |
| FY2021 | – | – | −8.5M | –% | -0.02 | −6.6M |
| FY2020 | – | – | −6.6M | –% | -0.03 | −6.1M |
| FY2019 | – | – | 1.1M | –% | -0.05 | – |
| FY2018 | – | – | −19.2M | –% | -0.16 | −3.9M |